NCT02676076View on ClinicalTrials.gov

TRIple in asthMA With uncontRolled pAtient on Medium streNgth of ICS + LABA

PHASE3CompletedINTERVENTIONAL
Enrollment

1,153

Participants

Timeline

Start Date

February 17, 2016

Primary Completion Date

May 17, 2018

Study Completion Date

May 17, 2018

Conditions
Asthma
Interventions
DRUG

CHF 5993 100/6/12.5 µg

DRUG

CHF 1535 100/6 µg

Trial Locations (1)

Unknown

Chiesi Clinical Trial Site 276814, Rostock

All Listed Sponsors
lead

Chiesi Farmaceutici S.p.A.

INDUSTRY

NCT02676076 - TRIple in asthMA With uncontRolled pAtient on Medium streNgth of ICS + LABA | Biotech Hunter | Biotech Hunter